All trials - page: 233

All trials

Displaying of results
Download as CSV
NCTID
Brief title
Sponsor
Design
Criteria
Status
Target enrollment
Study phase & design
Primary intervention type
Primary potential benefit
Outcome measure
Follow up
Start date
First posted
Location
NCT05622994Effects of CB1 Antagonist/Reverse Agonist Rimonabant on Walking Abilities in Incomplete Spinal Cord InjuryHospital Nacional de Parapléjicos de Toledo
  • Age 18 - 75 yrs
  • Level C4-L1
  • AIS C, D
  • ≥ 1 years
  • NOT have severe bone, kidney, or liver dysfunction
  • NOT have hypothyroidism
80PHASE2DrugGeneral health
  • 10 Meter Walking Test (10 MWT)
  • 6-Minute Walk Test (6MWT)
  • Ashworth and Modified Ashworth Scale (MAS)
  • European Quality of Life Five Dimension Five Level Scale (EQ-5D-5L)
  • Fatigue Severity Scale (FSS)
  • Hospital Anxiety and Depression Scale (HADS)
  • Numeric Pain Rating Scale
  • Penn Spasm Frequency Scale (PSFS)
  • Spinal Cord Independence Measure (SCIM)
120 days01 November 202221 November 20221
NCT05757830PURO - PUlmonary Rehabilitation With O-RAGT PlatformFondazione Don Carlo Gnocchi Onlus
  • Age 18 - 90 yrs
  • Level T2-S5
  • AIS B, C, D
  • All
  • Able to use a walker.
Ended20NATechnologyStanding/walking/mobility
  • 2 Minute Walk Test
48 hours23 December 202207 March 20234
NCT05646810Impact of Peripheral Afferent Input on Central Neuropathic PainUniversity of Aarhus
  • Age 18 - 80 yrs
  • Level C1-T12
  • AIS A, B, C, D
  • ≥ 1 years
20NADrugPain
  • Numeric Pain Rating Scale
95 minutes01 December 202212 December 20220
NCT05705453Epidural Stimulation After Neurologic Damage: Long-Term OutcomesUniversity of Minnesota
  • Age ≥ 22 yrs
  • Level C5-S5
  • AIS A, B
  • ≥ 1 years
  • HAVE an existing and functional implanted spinal cord stimulator system that is FDA approved
  • NOT have current or anticipated need for opioid pain medication preventing participation in the rehabilitation program
  • NOT have received Botox injections in the last six months
Recruiting50NATechnologyArm/hand function
  • Surface Electromyography (sEMG)
10 years01 March 202330 January 20231
NCT03898804An Early Feasibility Study of the ReHAB SystemUniversity Hospitals Cleveland Medical CenterSingle Group Assignment
  • Age 22 - 65 yrs
  • Level C1-C8
  • AIS
  • ≥ 12 months
  • Be at least 12 months post onset of tetraplegia.
  • Not have an implanted stimulator (e.g. pacemaker or stimulators (of the spinal cord, deep brain, vagus nerve), cochlear implant, or defibrillator.
  • Not be ventilator dependent.
Recruiting12Not ApplicableTechnologyGeneral health
  • Grasp and Release Test (GRT)
  • Lawton Instrumental Activities of Daily Living scale (IADL)
13 months09 April 201902 April 20191
NCT05601661Safety and Feasibility of Paired Vagus Nerve Stimulation With Rehabilitation for Improving Upper Extremity Function in People With Cervical Spinal Cord InjuryThe University of Texas Health Science Center, Houston
  • Age ≥ 18 yrs
  • Level C1-C8
  • AIS B, C, D
  • ≥ 12 months
  • NOT have prior history of vagus nerve injury
Ended6NATechnologyArm/hand function
  • Capabilities of Upper Extremity Instrument (CUE- Q and CUE-T)
  • Graded Redefined Assessment of Strength, Sensibility and Prehension (GRASSP)
  • Spinal Cord Independence Measure (SCIM)
  • Toronto Rehabilitation Institute Hand Function Test
132 days after enrollment15 June 202301 November 20221